Skip to main content
. 2015 Oct 22;5:15553. doi: 10.1038/srep15553

Figure 2. Passive immunization with pcAbs protect mice from lethal S. aureus challenge.

Figure 2

Mice were infected intravenously with 100 μl of a lethal dose of S. aureus. 100 μl of each pcAb (20 mg/ml) was injected intravenously 2 h post infection and the survival rate for each group was monitored for 10 days after the initial infection. (A) Survival rates of mice (n = 10) infected with MRSA252 and passively immunized with different kind of pcAbs, as indicated. (B) Survival rates of mice (n = 10) infected with MRSA252 and passively immunized with different concentration of SAvac-pcAb, as indicated. (C–F) Survival rates of mice (n = 10) infected with different clinical strains of S. aureus and passively immunized with SAvac-pcAb. The differences between vaccinated and PBS control mice were presented as p-value.